MetaCap

Veraxa Biotech (VRXA) News

NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.04+0.01 (+0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VRXA news summary

We found 2 recent headlines mentioning Veraxa Biotech (VRXA): 0 in the past week and 0 in the past 30 days, most often from Business Insider, GlobeNewswire. For price context, VRXA is up 0.97% at $1.04. The most recent story, "VERAXA Biotech (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline", was published by Business Insider on Oct 21, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Veraxa Biotech headlines

Compare VRXA